A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma
about
A-to-I editing of coding and non-coding RNAs by ADARsNew Insights into the Biological Role of Mammalian ADARs; the RNA Editing ProteinsThe genetic and epigenetic alterations in human hepatocellular carcinoma: a recent updateFunctions of the RNA Editing Enzyme ADAR1 and Their Relevance to Human DiseasesRNA2DNAlign: nucleotide resolution allele asymmetries through quantitative assessment of RNA and DNA paired sequencing dataComplex regulation of ADAR-mediated RNA-editing across tissuese23D: database and visualization of A-to-I RNA editing sites mapped to 3D protein structures.Overexpression of adenosine deaminase acting on RNA 1 in chordoma tissues is associated with chordoma pathogenesis by reducing miR‑125a and miR‑10a expressionADAR2 regulates RNA stability by modifying access of decay-promoting RNA-binding proteins.ADAR1 and MicroRNA; A Hidden Crosstalk in Cancer.An RNA editor, adenosine deaminase acting on double-stranded RNA (ADAR1).Association between targeted somatic mutation (TSM) signatures and HGS-OvCa progressionAlternative splicing of human NT5E in cirrhosis and hepatocellular carcinoma produces a negative regulator of ecto-5'-nucleotidase (CD73).Somatic mutations, viral integration and epigenetic modification in the evolution of hepatitis B virus-induced hepatocellular carcinomaADAR2-mediated editing of miR-214 and miR-122 precursor and antisense RNA transcripts in liver cancersAn RNA editing fingerprint of cancer stem cell reprogramming.Alternative applications for distinct RNA sequencing strategies.Liver cancer oncogenomics: opportunities and dilemmas for clinical applications.The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.RNA editing of microRNA prevents RNA-induced silencing complex recognition of target mRNA.RNA Editing Modulates Human Hepatic Aryl Hydrocarbon Receptor Expression by Creating MicroRNA Recognition Sequence.The Extent of mRNA Editing Is Limited in Chicken Liver and Adipose, but Impacted by Tissular Context, Genotype, Age, and Feeding as Exemplified with a Conserved Edited Site in COG3.A novel IGH@ gene rearrangement associated with CDKN2A/B deletion in young adult B-cell acute lymphoblastic leukemia.Genomic Characterization of Esophageal Squamous Cell Carcinoma Reveals Critical Genes Underlying Tumorigenesis and Poor PrognosisGene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesisRNA editing in RHOQ promotes invasion potential in colorectal cancerRNA-binding proteins as molecular links between cancer and neurodegeneration.A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.RNA editing is induced by type I interferon in esophageal squamous cell carcinoma.Identification of Diverse Adenosine-to-Inosine RNA Editing Subtypes in Colorectal Cancer.ADAR1 Prevents Liver Injury from Inflammation and Suppresses Interferon Production in Hepatocytes.Editing inducer elements increases A-to-I editing efficiency in the mammalian transcriptome.Rewriting the transcriptome: adenosine-to-inosine RNA editing by ADARs.An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer.Circular RNA expression is suppressed by androgen receptor (AR)-regulated adenosine deaminase that acts on RNA (ADAR1) in human hepatocellular carcinoma.RNA editing of AZIN1 induces the malignant progression of non-small-cell lung cancers.Editing liver tumours.Regulatory RNA Editing Sites in Cancer: Prediction and Beyond.The role of A-to-I RNA editing in cancer development.Identification of important long non-coding RNAs and highly recurrent aberrant alternative splicing events in hepatocellular carcinoma through integrative analysis of multiple RNA-Seq datasets.
P2860
Q26773402-13CCDE58-641B-4B3C-8349-5168BBF377C3Q26782034-4F15F9E6-46B1-47D0-9CB3-6BCF72ED9C2CQ27003050-24F05C5B-0C05-47C0-BF91-F81AEFD85ABAQ28078188-796CF738-300A-41FD-B235-257EF277BA3AQ28586795-3776FA89-504B-4DB7-8BF7-F31BE74C9EFBQ28602546-C9DF0B76-591C-4B57-9836-17E2B46FB8E2Q30387791-D691EDF1-7113-42A1-974A-D11798A1CDABQ33275542-54CB088C-CF77-4434-BFFC-D874506DE0F4Q33580377-DCA04461-2858-4675-8E51-8246AF87E905Q33624639-6E9A81CB-84A9-4F21-88C2-7989BC2D0917Q33714407-A51371D3-A5A0-49BE-A090-6977A35E9AB1Q34536160-3FEB4E37-7385-4B73-AEB9-226C52D79EEDQ34680354-1D239DC4-26AB-4982-98F8-B7278F4F3FEDQ35029955-054E0DE3-C8C1-46EB-A8B2-1DE8DDA30DF4Q35079974-6251B0BB-2BE4-4F97-BC90-A593DD9D1122Q35124728-CABFA3DC-6EE0-42EC-9CB9-B9E4397EBD2DQ35269902-50804834-67FC-468A-BB3C-E286EAD3699FQ35913384-EA2945DF-F920-4D65-845A-1FE8F64BD04BQ36161920-D415FBC2-6706-4A28-BE07-1C58AB0B3C83Q36435526-FD4A0259-6B74-435D-9B47-046A144C898EQ36442437-3568347A-7BC8-4F94-B41F-8D9A5A6B87F0Q36574535-A5106201-340D-4B2F-B1B3-921C3B35027EQ36640716-97940167-07A4-4ADB-B5B8-AB1EFF7BA7A3Q36802961-16A2726F-2507-40EE-821D-3AFBBA4BA9F1Q36828167-922E58B0-5893-4231-8D70-580D1B70A1A0Q37689373-8EF81AE0-22C5-41ED-BBF5-B7B6D38E4A7AQ38251313-E0A493BE-389B-4ACE-AC6C-89149506F36BQ38289096-9FD6E47B-4F10-459C-9327-7D6D10616FA6Q38697151-97F3E35A-3F80-4056-96E4-696CA6E700CEQ38978521-7C765559-5C22-4FB1-A1F1-9425D84582C2Q41760086-8C9469A8-9395-4B37-A978-A1A0A9F95299Q42643659-BD7CB6E8-2532-47AD-AF00-1B7AA8CB89B3Q47174263-B5A9BB39-E808-45AF-97E2-7714C77CE2F3Q47268042-A6C66ADB-43C9-4E91-A34F-60F69071F5CFQ47586536-90C8C164-F579-40CC-81C2-EBA03EFF053FQ47789946-3CEDF716-03EF-4D71-98FE-8E8079BFD57DQ47954691-13A10CFE-C532-426B-9CA3-1CB7B1E76FA5Q49609373-7F8CFAEE-8BF9-4698-A59E-56139A940C3BQ50060481-11327D35-EE20-46B0-86E4-FBA092E21E00Q53233480-5BEB2069-C000-4AE3-BB3F-D3AE29941AC7
P2860
A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A disrupted RNA editing balanc ...... human hepatocellular carcinoma
@ast
A disrupted RNA editing balanc ...... human hepatocellular carcinoma
@en
A disrupted RNA editing balanc ...... human hepatocellular carcinoma
@nl
type
label
A disrupted RNA editing balanc ...... human hepatocellular carcinoma
@ast
A disrupted RNA editing balanc ...... human hepatocellular carcinoma
@en
A disrupted RNA editing balanc ...... human hepatocellular carcinoma
@nl
prefLabel
A disrupted RNA editing balanc ...... human hepatocellular carcinoma
@ast
A disrupted RNA editing balanc ...... human hepatocellular carcinoma
@en
A disrupted RNA editing balanc ...... human hepatocellular carcinoma
@nl
P2093
P2860
P50
P3181
P1433
P1476
A disrupted RNA editing balanc ...... human hepatocellular carcinoma
@en
P2093
Chi Ho Lin
Kol Jia Yong
Raymond Kwok Kei Chow
Tim Hon Man Chan
Vanessa Hui En Ng
Yangyang Song
P2860
P304
P3181
P356
10.1136/GUTJNL-2012-304037
P407
P577
2013-06-13T00:00:00Z